Fortress Biotech Inc (FBIO)
1.82
+0.02
(+1.11%)
USD |
NASDAQ |
Apr 15, 16:00
1.80
-0.02
(-1.10%)
After-Hours: 20:00
Fortress Biotech Revenue (TTM): 84.51M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 84.51M |
| September 30, 2023 | 80.97M |
| June 30, 2023 | 62.75M |
| March 31, 2023 | 64.25M |
| December 31, 2022 | 75.74M |
| September 30, 2022 | 77.62M |
| June 30, 2022 | 82.17M |
| March 31, 2022 | 81.13M |
| December 31, 2021 | 68.79M |
| September 30, 2021 | 64.26M |
| June 30, 2021 | 52.65M |
| March 31, 2021 | 44.27M |
| December 31, 2020 | 45.60M |
| September 30, 2020 | 42.98M |
| June 30, 2020 | 43.28M |
| March 31, 2020 | 43.07M |
| Date | Value |
|---|---|
| December 31, 2019 | 36.63M |
| September 30, 2019 | 34.49M |
| June 30, 2019 | 29.89M |
| March 31, 2019 | 27.46M |
| December 31, 2018 | 26.88M |
| September 30, 2018 | -107.13M |
| June 30, 2018 | -65.42M |
| March 31, 2018 | -21.53M |
| December 31, 2017 | 17.24M |
| September 30, 2017 | 154.88M |
| June 30, 2017 | 108.97M |
| March 31, 2017 | 60.50M |
| December 31, 2016 | 16.48M |
| September 30, 2016 | 4.203M |
| June 30, 2016 | 3.253M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
29.89M
Minimum
Jun 2019
84.51M
Maximum
Dec 2023
58.69M
Average
62.75M
Median
Jun 2023
Revenue (TTM) Benchmarks
| Journey Medical Corp | 79.18M |
| Avenue Therapeutics Inc | -- |
| Checkpoint Therapeutics Inc | 0.103M |
| Mustang Bio Inc | -- |
| NovaBay Pharmaceuticals Inc | 14.73M |